Clinical Trial Update: Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial is evaluating the safety and potential efficacy of BBM-D101 for Duchenne muscular dystrophy. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• BBM-D101

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Duchenne Muscular Dystrophy (DMD) | EARLY_Phase 1 | Status: RECRUITING